NeoGenomics (NEO) Competitors $13.54 +0.54 (+4.15%) (As of 10/10/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NEO vs. ETSY, MPLN, QXO, LYFT, TNET, NVEI, MARA, CLVT, ATHM, and ALITShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Etsy (ETSY), MultiPlan (MPLN), QXO (QXO), Lyft (LYFT), TriNet Group (TNET), Nuvei (NVEI), Marathon Digital (MARA), Clarivate (CLVT), Autohome (ATHM), and Alight (ALIT). These companies are all part of the "business services" industry. NeoGenomics vs. Etsy MultiPlan QXO Lyft TriNet Group Nuvei Marathon Digital Clarivate Autohome Alight NeoGenomics (NASDAQ:NEO) and Etsy (NASDAQ:ETSY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking. Do analysts recommend NEO or ETSY? NeoGenomics presently has a consensus target price of $19.89, suggesting a potential upside of 46.89%. Etsy has a consensus target price of $71.14, suggesting a potential upside of 43.28%. Given NeoGenomics' stronger consensus rating and higher probable upside, equities analysts clearly believe NeoGenomics is more favorable than Etsy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeoGenomics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Etsy 3 Sell rating(s) 12 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.26 Does the media prefer NEO or ETSY? In the previous week, Etsy had 12 more articles in the media than NeoGenomics. MarketBeat recorded 18 mentions for Etsy and 6 mentions for NeoGenomics. NeoGenomics' average media sentiment score of 0.91 beat Etsy's score of 0.01 indicating that NeoGenomics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeoGenomics 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Etsy 4 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Which has better earnings and valuation, NEO or ETSY? Etsy has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Etsy, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeoGenomics$591.64M2.93-$87.97M-$0.62-21.84Etsy$2.75B2.07$307.57M$2.1523.09 Is NEO or ETSY more profitable? Etsy has a net margin of 10.36% compared to NeoGenomics' net margin of -12.50%. NeoGenomics' return on equity of -2.72% beat Etsy's return on equity.Company Net Margins Return on Equity Return on Assets NeoGenomics-12.50% -2.72% -1.53% Etsy 10.36%-51.94%12.29% Which has more risk and volatility, NEO or ETSY? NeoGenomics has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Comparatively, Etsy has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500. Do institutionals & insiders have more ownership in NEO or ETSY? 98.5% of NeoGenomics shares are owned by institutional investors. Comparatively, 99.5% of Etsy shares are owned by institutional investors. 1.3% of NeoGenomics shares are owned by company insiders. Comparatively, 2.6% of Etsy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in NEO or ETSY? Etsy received 342 more outperform votes than NeoGenomics when rated by MarketBeat users. However, 70.86% of users gave NeoGenomics an outperform vote while only 59.37% of users gave Etsy an outperform vote. CompanyUnderperformOutperformNeoGenomicsOutperform Votes50170.86% Underperform Votes20629.14% EtsyOutperform Votes84359.37% Underperform Votes57740.63% SummaryEtsy beats NeoGenomics on 12 of the 19 factors compared between the two stocks. Ad DTIMassive shakeup in defense contractingThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.You need to check out the full story right here. Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsTesting laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.67B$2.98B$5.41B$8.54BDividend YieldN/A1.48%4.44%4.15%P/E Ratio-21.84N/A92.6512.72Price / Sales2.932.111,290.4789.27Price / Cash46.0530.5338.2933.51Price / Book1.832.734.584.46Net Income-$87.97M$106.45M$114.32M$227.11M7 Day Performance-2.87%-3.83%-0.87%0.67%1 Month Performance-16.98%-21.95%14.26%11.79%1 Year Performance8.32%-21.33%24.02%19.04% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics2.8127 of 5 stars$13.54+4.2%$19.89+46.9%+6.3%$1.67B$591.64M-21.842,100ETSYEtsy4.5668 of 5 stars$51.19-3.0%$70.22+37.2%-22.1%$5.99B$2.77B23.372,420Short Interest ↑MPLNMultiPlan0.8657 of 5 stars$9.13+1.4%$5.50-39.8%N/A$5.89B$954.92M-9.322,800Gap DownQXOQXO0.9974 of 5 stars$13.67-2.2%N/AN/A$5.60B$57.11M-7.77195Short Interest ↑LYFTLyft4.081 of 5 stars$12.51-0.5%$15.65+25.1%+11.0%$5.05B$5.10B-26.622,945Gap UpTNETTriNet Group3.8998 of 5 stars$96.66-1.6%$118.40+22.5%-19.2%$4.80B$4.92B15.853,600Positive NewsNVEINuvei2.8957 of 5 stars$33.38+0.1%$32.21-3.5%+109.1%$4.67B$1.31B-834.502,202Positive NewsMARAMarathon Digital3.4269 of 5 stars$15.99-2.0%$19.61+22.7%+80.0%$4.52B$564.95M7.449Analyst ForecastCLVTClarivate2.288 of 5 stars$6.53-2.0%$7.71+18.1%+0.0%$4.36B$2.60B-3.9312,000Positive NewsATHMAutohome2.569 of 5 stars$33.94-0.3%$28.00-17.5%+8.9%$4.26B$7.30B16.095,511Short Interest ↓Positive NewsALITAlight2.7599 of 5 stars$7.20-1.5%$10.75+49.3%+4.4%$4.04B$3.36B-11.6118,000Short Interest ↑ Related Companies and Tools Related Companies: Etsy Alternatives MultiPlan Alternatives QXO Alternatives Lyft Alternatives TriNet Group Alternatives Nuvei Alternatives Marathon Digital Alternatives Clarivate Alternatives Autohome Alternatives Alight Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NEO) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.